As a proof of concept, Kershaw et al. were among the first ones to demonstrate that the introduction of CXCR2, via retroviral vector transduction of peripheral blood derived T cells, was a feasible technique to redirect the cells towards the tumor, resulting in proper IFN-γ response when activated by their cognate chemokine [92]. Here, CXCR2 is linked to neoplasm.